News

Antibiotic resistance is a globally growing health threat, which is projected to take more lives than all forms of cancer combined by 2050 if it cannot be controlled. (1) Nowadays, there is a general ...
Fintel reports that on July 1, 2025, UBS initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Buy recommendation.